G Emile

G Emile

Affiliations

Departments of Clinical Research Unit and Medical Oncology, Caen, France.
Institut Normand du Sein, Centre François Baclesse, Caen, France.

Réseau de co-auteurs

George Emile 6 collaborations

Jean-Marc Ferrero 2 collaborations

Thomas Bachelot 2 collaborations

Etienne Brain 2 collaborations

Delphine Loirat 2 collaborations

Anthony Gonçalves 2 collaborations

William Jacot 2 collaborations

Véronique Diéras 2 collaborations

Charline Lasnon 2 collaborations

Anne-Claire Hardy-Bessard 1 collaboration

Fabien Brocard 1 collaboration

Florian Clatot 1 collaboration

Alain Lortholary 1 collaboration

Benoît You 1 collaboration

Julien Grenier 1 collaboration

Jérôme Martin-Babau 1 collaboration

Brigitte Lucas 1 collaboration

Jérôme Meunier 1 collaboration

Aude-Marie Savoye 1 collaboration

Adina Marti 1 collaboration

Raymond Despax 1 collaboration

Isabelle Moullet 1 collaboration

J Perrier 1 collaboration

M Duivon 1 collaboration

P Clochon 1 collaboration

S Rehel 1 collaboration

F Doidy 1 collaboration

J M Grellard 1 collaboration

C Segura-Djezzar 1 collaboration

J Geffrelot 1 collaboration

D Allouache 1 collaboration

C Levy 1 collaboration

S Polvent 1 collaboration

F Viader 1 collaboration

F Eustache 1 collaboration

F Joly 1 collaboration

B Giffard 1 collaboration

Fanny Le Du 1 collaboration

Matthieu Carton 1 collaboration

Mahasti Saghatchian 1 collaboration

Barbara Pistilli 1 collaboration

Laurence Vanlemmens 1 collaboration

Thomas Vermeulin 1 collaboration

Mony Ung 1 collaboration

Marie Robert 1 collaboration

Anne Jaffre 1 collaboration

Isabelle Desmoulins 1 collaboration

Christelle Jouannaud 1 collaboration

Lionel Uwer 1 collaboration

Jean Marc Ferrero 1 collaboration

Marie-Ange Mouret-Reynier 1 collaboration

Michaël Chevrot 1 collaboration

Suzette Delaloge 1 collaboration

Adeline Morel 1 collaboration

Nicolas Aide 1 collaboration

Angélique Da Silva 1 collaboration

Zoé Neviere 1 collaboration

Cécile Blanc-Fournier 1 collaboration

Anne-Valérie Guizard 1 collaboration

Nicolas Elie 1 collaboration

Florence Giffard 1 collaboration

Justine Lequesne 1 collaboration

Laurent Poulain 1 collaboration

François-Clément Bidard 1 collaboration

Nicolas Kiavue 1 collaboration

Sylvain Dureau 1 collaboration

Amir Kadi 1 collaboration

Hugues Bourgeois 1 collaboration

Sylvain Ladoire 1 collaboration

Hervé Naman 1 collaboration

Florence Dalenc 1 collaboration

Joseph Gligorov 1 collaboration

Marc Espié 1 collaboration

Sophie Frank 1 collaboration

Luc Cabel 1 collaboration

Laure Cayrefourcq 1 collaboration

Cécile Simondi 1 collaboration

Frédérique Berger 1 collaboration

Catherine Alix-Panabières 1 collaboration

Jean-Yves Pierga 1 collaboration

Tristan Martin 1 collaboration

Mylène Duivon 1 collaboration

Nicolas Bessot 1 collaboration

Jean-Michel Grellard 1 collaboration

Sébastien Polvent 1 collaboration

Lucie Raoul 1 collaboration

Fausto Viader 1 collaboration

Francis Eustache 1 collaboration

Florence Joly 1 collaboration

Bénédicte Giffard 1 collaboration

Joy Perrier 1 collaboration

D Presti 1 collaboration

J Havas 1 collaboration

D Soldato 1 collaboration

P Lapidari 1 collaboration

E Martin 1 collaboration

B Pistilli 1 collaboration

C Jouannaud 1 collaboration

O Rigal 1 collaboration

M Fournier 1 collaboration

P Soulie 1 collaboration

M-A Mouret-Reynier 1 collaboration

C Tarpin 1 collaboration

M Campone 1 collaboration

S Guillermet 1 collaboration

A-L Martin 1 collaboration

S Everhard 1 collaboration

A Di Meglio 1 collaboration

Affiliations

Publications (8)

First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA study.

Sleep macro- and microstructure in breast cancer survivors.

Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program.

Baseline and early

Potential of PSMA for breast cancer in nuclear medicine: digital quantitative immunohistochemical analysis and implications for a theranostic approach.

Efficacy of Circulating Tumor Cell Count-Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: The STIC CTC Randomized Clinical Trial.

Rest activity rhythms characteristics of breast cancer women following endocrine therapy.

Factors associated with enrolment in clinical trials among women with early-stage breast cancer.

Réseau de co-auteurs